Citius Pharmaceuticals Inc (NQ: CTXR )

1.140 USD +0.040 (+3.64%)

Official Closing Price Updated: 5:51 PM EDT, Oct 23, 2020 Add to My Watchlist

Price and Volume

Volume	351,800
Open	1.110
Bid (Size)	1.130 (65)
Ask (Size)	1.140 (5)
Prev. Close	1.100
Today's Range	1.100 - 1.140
52wk Range	0.4000 - 1.970
Shares Outstanding	10,677,222
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) to NoveCite for COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) and Other Acute Respiratory Conditions

October 13, 2020

- Novellus's iMSCs are derived from a single donor using its patented mRNA-based, footprint-free cell reprogramming technology

Citius Pharmaceuticals Signs an Exclusive Worldwide Licensing Agreement with Novellus Therapeutics for Unique iMSC-Therapy for Acute Inflammatory Respiratory Conditions including COVID-19 Related Acut

October 07, 2020

-- NoveCite, a newly formed subsidiary of Citius Pharmaceuticals, Inc., plans to develop, manufacture and commercialize a unique induced mesenchymal stem cells (NC-iMSCs)

Performance

YTD	+15.04%	+15.04%
1 Month	+10.68%	+10.68%
3 Month	-18.57%	-18.57%
6 Month	+40.74%	+40.74%
1 Year	+103.57%	+103.57%

More News

Citius's Mino-Lok trial sites resupplied with registration batch product

September 30, 2020

Citius Pharmaceuticals Reports Positive Results from Recent Data Monitoring Committee Meeting for Mino-Lok Phase 3 Trial

September 29, 2020

Citius Pharmaceuticals Achieves Chemical Manufacturing and Control Milestones for Mino-Lok®

September 22, 2020

Citius Files Addendum to Mino-Lok Phase 3 Trial Record Keeping Protocol to Advance Trials with COVID-19 Compliance

September 15, 2020

Citius Pharmaceuticals to Present at H.C. Wainwright Virtual 22nd Annual Global Investment Conference

September 08, 2020

Citius Pharmaceuticals to Present at the LD 500 Virtual Conference

August 27, 2020

Citius Pharmaceuticals Announces Improved Design and Expansion of Intellectual Property for Mino-Wrap

August 26, 2020

Citius Pharmaceuticals to Present at the MoneyShow Las Vegas Virtual Expo

August 13, 2020

Citius Pharmaceuticals Announces Closing of $9.6 Million Bought Deal Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares

August 10, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.